Ingrid and her daughter Lola, who is now three years old / GEICAM
–
Ruth was diagnosed with breast cancer during her pregnancy, and at that point, her world fell apart, she says. However, after the harsh news, Ruth decided to face the situation with a positive attitude.
“The first thing you think is that your world is falling apart and, in this case, the life you carry inside, which makes you sink into discouragement and pessimism. But I am convinced that trying to develop a positive attitude as soon as possible is essential”, He highlights.
Like Ruth, Ingrid had the same experience when she was in the 36th week of pregnancy. In her case, it was the joy of being able to hold her daughter in her arms earlier that gave her the strength to move forward, as she recalls.
“I was diagnosed with breast cancer, a stage II infiltrating ductal carcinoma. At that moment, I had an intense mixture of sensations. Among them, fear for not knowing what I was facing and for the uncertainty, and happiness because I could have my daughter in my arms earlier than planned.“, account.
After delivery, she underwent an operation, six months of chemotherapy and one of radiation therapy.
“I am convinced that all the side effects of chemotherapy and the giddiness that this process produces were alleviated by the joy that motherhood brought me”, He assures.
Both are participants of the campaign campaign ‘Make history with your story ‘, launched by the GEICAM Breast Cancer Research Group in commemoration, within the framework of Mother’s Day.
Deepen knowledge
This campaign, as explained by GEICAM, seeks to encourage women who have had breast cancer
during pregnancy or one year after it, to participate with their medical history in the project ‘Breast cancer and the desire to be a mother’.
Likewise, they also include in the study those women who, after having had breast cancer, wish to be or have been mothers after cancer.
The project ‘Breast cancer and the desire to be a mother‘, meanwhile, has the objective of gathering clinical information through experiences and, thus, deepening the knowledge about the relationships that exist between pregnancy and breast cancer.
“The relationship between the physiological changes that occur in pregnancy and in lactation with the development of the tumor is being studied ”, explains Dr. Juan de la Haba, director of the Breast and Clinical Research Unit of the Reina Sofía University Hospital in Córdoba and member of GEICAM.
“We do not have official data on this type of patients nor is there a national registry, so the study will allow us to have a picture of the reality of breast cancer and pregnancy”, adds Dr. Begoña Bermejo, from INCLIVA’s Breast Cancer Biology Research Group and from the Department of Medical Oncology of the Hospital Clínico de Valencia, member of the GEICAM board of directors.
Tumor analysis
In both cases, they detail from GEICAM, the final purpose of the study is to anticipate this situation and design strategies aimed at achieving both safe pregnancies and pregnancies.
In the words of Dr. Bermejo, thanks to the clinical information of these women, the project will analyze molecular data of the tumor and blood.
With this, he exposes, it will be possible to determine some biological or genetic characteristic that differentiates breast cancers.
“Or to know if genetically these women have a higher risk of developing this tumor during pregnancy”Continues Dr. Bermejo.
Preserve fertility
With the delay in the age of the first pregnancy and the incorporation of women into working life, experts warn that the number of cases of women who, when they receive the diagnosis of breast cancer, have not yet fulfilled their wish, has increased. of being mothers.
To deal with this situation, GEICAM reminds that there are fertility preservation techniques for those women who are going to receive a treatment that may limit the possibilities of becoming mothers.
“The preservation of ovules, the use of drugs to keep the ovary at rest, or the cryopreservation of ovarian tissue are some of those that have proven to be more effective”Concludes Dr. De la Haba.